@damienleith.bsky.social
PhD student with an interest in the early detection of MASLD in T2D, working on the iDiabetes precision medicine platform.
Very excited to have our abstract review of high level results of MASLD screening within the iDiabetes precision platform in @emjreviews.bsky.social Hepatology. Check it out at:
www.emjreviews.com/hepatology/a...
www.emjreviews.com/hepatology/a...
Integrated MASLD Screening Within the Precision iDiabetes Platform Achieves Universal FIB-4 Screening, Automated Secondary Care Referral, and New cACLD and HCC Diagnoses
Fibrosis-4 (FIB-4) screening for people with Type 2 diabetes (T2D) is recommended; however, screening and hepatology linkage for...
www.emjreviews.com
July 16, 2026 at 5:36 PM
Very excited to have our abstract review of high level results of MASLD screening within the iDiabetes precision platform in @emjreviews.bsky.social Hepatology. Check it out at:
www.emjreviews.com/hepatology/a...
www.emjreviews.com/hepatology/a...
Reposted
Every country in this list is less dependent on energy imports if it gets on track for a net-zero world, including the US. Though US gains are the least!
From BNEF's New Energy Outlook for 2026.
From BNEF's New Energy Outlook for 2026.
June 17, 2026 at 12:37 PM
Every country in this list is less dependent on energy imports if it gets on track for a net-zero world, including the US. Though US gains are the least!
From BNEF's New Energy Outlook for 2026.
From BNEF's New Energy Outlook for 2026.
Reposted
A huge betrayal.
Won't lower bills. Won't give us more energy security. Won't insulate from price shocks.
And sends a clear message to the world that we are backing new oil and gas drilling.
www.lbc.co.uk/article/ed-m...
Won't lower bills. Won't give us more energy security. Won't insulate from price shocks.
And sends a clear message to the world that we are backing new oil and gas drilling.
www.lbc.co.uk/article/ed-m...
Ed Miliband to give green light to first major North Sea gasfield project in decade | LBC
The energy secretary is expected to approve Jackdaw drilling as the Iran war puts pressure on the government over energy security fears
www.lbc.co.uk
April 3, 2026 at 8:56 AM
A huge betrayal.
Won't lower bills. Won't give us more energy security. Won't insulate from price shocks.
And sends a clear message to the world that we are backing new oil and gas drilling.
www.lbc.co.uk/article/ed-m...
Won't lower bills. Won't give us more energy security. Won't insulate from price shocks.
And sends a clear message to the world that we are backing new oil and gas drilling.
www.lbc.co.uk/article/ed-m...
Reposted
🎙️ #BavenoVIII takeaways — distilled by @tom_marjot, @MattiasMandorf1 & Cristina Ripoll 🎯
🎧 Listen now:
- EASL Campus: easlcampus.eu/tltm/episode...
- Spotify: open.spotify.com/episode/4Tfv...
- Apple: podcasts.apple.com/us/podcast/t...
🎧 Listen now:
- EASL Campus: easlcampus.eu/tltm/episode...
- Spotify: open.spotify.com/episode/4Tfv...
- Apple: podcasts.apple.com/us/podcast/t...
EASL Campus
Continue your hepatology and liver-related disease education though our multi-disciplinary, open access eLearning platform EASL Campus. Sign up to access state-of-the-art digital courses and resources...
easlcampus.eu
April 1, 2026 at 3:22 PM
🎙️ #BavenoVIII takeaways — distilled by @tom_marjot, @MattiasMandorf1 & Cristina Ripoll 🎯
🎧 Listen now:
- EASL Campus: easlcampus.eu/tltm/episode...
- Spotify: open.spotify.com/episode/4Tfv...
- Apple: podcasts.apple.com/us/podcast/t...
🎧 Listen now:
- EASL Campus: easlcampus.eu/tltm/episode...
- Spotify: open.spotify.com/episode/4Tfv...
- Apple: podcasts.apple.com/us/podcast/t...
Our editorial published in this months JIM - @liverepi.bsky.social & colleagues identify MASLD in 18.1% of 28,000 middle-aged Swedish adults, define MASLD risk factors that translate into actionable advice for patients and identify risk with any alcohol use and possible deleterious effects of coffee
New Editorial! Put down your soda, get off the couch and walk past the bar.
➡️ Lifestyle risk factors for metabolic dysfunction-associated steatotic liver disease.
🔗 doi.org/10.1111/joim.70076
👉 Also, read the original article: doi.org/10.1111/joim.70071
#MASLD #liver #disease #lifestyle
➡️ Lifestyle risk factors for metabolic dysfunction-associated steatotic liver disease.
🔗 doi.org/10.1111/joim.70076
👉 Also, read the original article: doi.org/10.1111/joim.70071
#MASLD #liver #disease #lifestyle
February 19, 2026 at 4:57 PM
Our editorial published in this months JIM - @liverepi.bsky.social & colleagues identify MASLD in 18.1% of 28,000 middle-aged Swedish adults, define MASLD risk factors that translate into actionable advice for patients and identify risk with any alcohol use and possible deleterious effects of coffee
Reposted
Delighted to share the evolution of @torchuk.bsky.social and our lessons learnt as a road map 🗺️ 🏥
Such a pleasure to work with talented colleagues across the UK to shape this and prime our project pipeline to improve outcomes in liver disease
doi.org/10.1136/flga...
#liversky #gastrosky #EVADE
Such a pleasure to work with talented colleagues across the UK to shape this and prime our project pipeline to improve outcomes in liver disease
doi.org/10.1136/flga...
#liversky #gastrosky #EVADE
February 9, 2026 at 11:03 AM
Delighted to share the evolution of @torchuk.bsky.social and our lessons learnt as a road map 🗺️ 🏥
Such a pleasure to work with talented colleagues across the UK to shape this and prime our project pipeline to improve outcomes in liver disease
doi.org/10.1136/flga...
#liversky #gastrosky #EVADE
Such a pleasure to work with talented colleagues across the UK to shape this and prime our project pipeline to improve outcomes in liver disease
doi.org/10.1136/flga...
#liversky #gastrosky #EVADE
Great article from Lazarus et al on the parallels today in the fight against MASLD with previous lessons learned from viral hepatitis
ICYMI: New online! Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease
Nature Reviews Gastroenterology & Hepatology, Published online: 30 January 2026; doi:10.1038/s41575-026-01174-zSteatotic liver disease (SLD), which might lead to cirrhosis and hepatocellular carcinoma, is on the rise worldwide. This Expert Recommendation draws on lessons learned to tackle viral hepatitis and proposes a framework for SLD screening and testing policies.
dlvr.it
February 5, 2026 at 8:44 PM
Great article from Lazarus et al on the parallels today in the fight against MASLD with previous lessons learned from viral hepatitis
Reposted
ICYMI: New online! Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease
Nature Reviews Gastroenterology & Hepatology, Published online: 30 January 2026; doi:10.1038/s41575-026-01174-zSteatotic liver disease (SLD), which might lead to cirrhosis and hepatocellular carcinoma, is on the rise worldwide. This Expert Recommendation draws on lessons learned to tackle viral hepatitis and proposes a framework for SLD screening and testing policies.
dlvr.it
February 5, 2026 at 8:42 PM
ICYMI: New online! Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease
Our editorial in Hepatology about the FMO (fibrotic/ at-risk MASH in obesity) score. Developed to identify At-risk MASH. Validated in 4 external cohort. It uses ALT, AST, triglycerides and HDL and is able to rule-our At-risk MASH with a NPV of 0.97 and predicts LRE.
journals.lww.com/hep/citation...
journals.lww.com/hep/citation...
journals.lww.com
December 15, 2025 at 10:31 PM
Our editorial in Hepatology about the FMO (fibrotic/ at-risk MASH in obesity) score. Developed to identify At-risk MASH. Validated in 4 external cohort. It uses ALT, AST, triglycerides and HDL and is able to rule-our At-risk MASH with a NPV of 0.97 and predicts LRE.
journals.lww.com/hep/citation...
journals.lww.com/hep/citation...
Reposted
Traction building nicely across the 🇬🇧
Any help with spreading the word and getting hospital sites involved in your regions would be greatly appreciated 🙏🏼
We are folding in patient trajectory as a novel angle - should be interesting!
#liversky
Any help with spreading the word and getting hospital sites involved in your regions would be greatly appreciated 🙏🏼
We are folding in patient trajectory as a novel angle - should be interesting!
#liversky
📢 #EVADE project update
🏥 33 hospital sites registered and counting!!
🇬🇧 site registration: redcap.link/evade
🚨 Due to prospective design we need teams AND approvals in place by 31/12 so we are synchronised for data collection in the new year. Lets go!
(1/1)
🏥 33 hospital sites registered and counting!!
🇬🇧 site registration: redcap.link/evade
🚨 Due to prospective design we need teams AND approvals in place by 31/12 so we are synchronised for data collection in the new year. Lets go!
(1/1)
November 25, 2025 at 9:03 PM
Traction building nicely across the 🇬🇧
Any help with spreading the word and getting hospital sites involved in your regions would be greatly appreciated 🙏🏼
We are folding in patient trajectory as a novel angle - should be interesting!
#liversky
Any help with spreading the word and getting hospital sites involved in your regions would be greatly appreciated 🙏🏼
We are folding in patient trajectory as a novel angle - should be interesting!
#liversky
Our paper published today in Frontline Gastro
18 months after introducing a decentralised Fibroscan service:
⇒Patient: 33 564 km and 16.1 days of travel saved.
⇒Environmental: 4929.4 kgCO2 of CO2 saved.
⇒Hospital services: 167 hospital appointments saved (=£43,587).
fg.bmj.com/content/flga...
18 months after introducing a decentralised Fibroscan service:
⇒Patient: 33 564 km and 16.1 days of travel saved.
⇒Environmental: 4929.4 kgCO2 of CO2 saved.
⇒Hospital services: 167 hospital appointments saved (=£43,587).
fg.bmj.com/content/flga...
fg.bmj.com
November 21, 2025 at 11:01 AM
Our paper published today in Frontline Gastro
18 months after introducing a decentralised Fibroscan service:
⇒Patient: 33 564 km and 16.1 days of travel saved.
⇒Environmental: 4929.4 kgCO2 of CO2 saved.
⇒Hospital services: 167 hospital appointments saved (=£43,587).
fg.bmj.com/content/flga...
18 months after introducing a decentralised Fibroscan service:
⇒Patient: 33 564 km and 16.1 days of travel saved.
⇒Environmental: 4929.4 kgCO2 of CO2 saved.
⇒Hospital services: 167 hospital appointments saved (=£43,587).
fg.bmj.com/content/flga...
Reposted
Fantastic to see the updated BSG/BASL decompensated cirrhosis admission bundle in print at FG
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter
fg.bmj.com/content/earl...
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter
fg.bmj.com/content/earl...
Decompensated cirrhosis: an update of the BSG/BASL admission care bundle
Acute decompensated cirrhosis (DC) and acute-on-chronic liver failure are common reasons for hospital admission that have a high in-hospital mortality rate (10%–20%). Patients require a detailed asses...
fg.bmj.com
April 16, 2025 at 6:54 PM
Fantastic to see the updated BSG/BASL decompensated cirrhosis admission bundle in print at FG
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter
fg.bmj.com/content/earl...
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter
fg.bmj.com/content/earl...